These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
412 related articles for article (PubMed ID: 20708852)
1. Stereotactic fractionated radiotherapy and LINAC radiosurgery in the treatment of vestibular schwannoma-report about both stereotactic methods from a single institution. Kopp C; Fauser C; Müller A; Astner ST; Jacob V; Lumenta C; Meyer B; Tonn JC; Molls M; Grosu AL Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1485-91. PubMed ID: 20708852 [TBL] [Abstract][Full Text] [Related]
2. Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience. Collen C; Ampe B; Gevaert T; Moens M; Linthout N; De Ridder M; Verellen D; D'Haens J; Storme G Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e503-9. PubMed ID: 21665381 [TBL] [Abstract][Full Text] [Related]
3. Symptomatic outcomes in relation to tumor expansion after fractionated stereotactic radiation therapy for vestibular schwannomas: single-institutional long-term experience. Aoyama H; Onodera S; Takeichi N; Onimaru R; Terasaka S; Sawamura Y; Shirato H Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):329-34. PubMed ID: 22704983 [TBL] [Abstract][Full Text] [Related]
4. Fractionated stereotactic radiotherapy in the treatment of vestibular schwannoma (acoustic neuroma): predicting the risk of hydrocephalus. Powell C; Micallef C; Gonsalves A; Wharram B; Ashley S; Brada M Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1143-50. PubMed ID: 20675080 [TBL] [Abstract][Full Text] [Related]
5. Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution. Combs SE; Volk S; Schulz-Ertner D; Huber PE; Thilmann C; Debus J Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):75-81. PubMed ID: 16111574 [TBL] [Abstract][Full Text] [Related]
6. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas. Combs SE; Welzel T; Schulz-Ertner D; Huber PE; Debus J Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):193-200. PubMed ID: 19604653 [TBL] [Abstract][Full Text] [Related]
7. Hearing preservation after radiotherapy for vestibular schwannomas is comparable to hearing deterioration in healthy adults and is accompanied by local tumor control and a highly preserved quality of life (QOL) as patients' self-reported outcome. Combs SE; Welzel T; Kessel K; Habermehl D; Rieken S; Schramm O; Debus J Radiother Oncol; 2013 Feb; 106(2):175-80. PubMed ID: 23333012 [TBL] [Abstract][Full Text] [Related]
8. Follow-up after gamma knife radiosurgery for vestibular schwannomas: volumetric and axial control rates. Timmer FC; Hanssens PE; van Haren AE; van Overbeeke JJ; Mulder JJ; Cremers CW; Graamans K Laryngoscope; 2011 Jul; 121(7):1359-66. PubMed ID: 21647893 [TBL] [Abstract][Full Text] [Related]
9. Fractionated stereotactic radiotherapy for acoustic neuromas: a prospective monocenter study of about 158 cases. Litre F; Rousseaux P; Jovenin N; Bazin A; Peruzzi P; Wdowczyk D; Colin P Radiother Oncol; 2013 Feb; 106(2):169-74. PubMed ID: 23219253 [TBL] [Abstract][Full Text] [Related]
10. Linear accelerator stereotactic radiosurgery for vestibular schwannomas: a UK series. Benghiat H; Heyes G; Nightingale P; Hartley A; Tiffany M; Spooner D; Geh JI; Cruickshank G; Irving RM; Sanghera P Clin Oncol (R Coll Radiol); 2014 Jun; 26(6):309-15. PubMed ID: 24636634 [TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up reveals low toxicity of radiosurgery for vestibular schwannoma. Rutten I; Baumert BG; Seidel L; Kotolenko S; Collignon J; Kaschten B; Albert A; Martin D; Deneufbourg JM; Demanez JP; Stevenaert A Radiother Oncol; 2007 Jan; 82(1):83-9. PubMed ID: 17182142 [TBL] [Abstract][Full Text] [Related]
12. Stereotactic radiosurgery for acoustic neuromas: what happens long term? Roos DE; Potter AE; Brophy BP Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1352-5. PubMed ID: 21700400 [TBL] [Abstract][Full Text] [Related]
13. Fractionated stereotactic radiotherapy of vestibular schwannomas accelerates hearing loss. Rasmussen R; Claesson M; Stangerup SE; Roed H; Christensen IJ; Cayé-Thomasen P; Juhler M Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e607-11. PubMed ID: 22560549 [TBL] [Abstract][Full Text] [Related]
14. [First experience of stereotactic radiation therapy for vestibular schwannoma using CyberKnife]. Zolotova SV; Golanov AV; Trunin IuIu; Galkin MV; Kotel'nikova TM; Antipina NA; Gorlachev GE; Nikonova NG; Pronin IN Zh Vopr Neirokhir Im N N Burdenko; 2012; 76(1):13-20; discussion 20. PubMed ID: 22629843 [TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of stereotactic radiosurgery (SRS) in patients with acoustic neuromas. Combs SE; Thilmann C; Debus J; Schulz-Ertner D Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1341-7. PubMed ID: 16464537 [TBL] [Abstract][Full Text] [Related]
17. Small vestibular schwannomas with no hearing: comparison of functional outcomes in stereotactic radiosurgery and microsurgery. Coelho DH; Roland JT; Rush SA; Narayana A; St Clair E; Chung W; Golfinos JG Laryngoscope; 2008 Nov; 118(11):1909-16. PubMed ID: 18849856 [TBL] [Abstract][Full Text] [Related]
18. Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2. Meijer OW; Vandertop WP; Lagerwaard FJ; Slotman BJ Neurosurgery; 2008 May; 62(5 Suppl):A37-42; discussion A42-3. PubMed ID: 18580779 [TBL] [Abstract][Full Text] [Related]
19. Conservative management versus stereotactic radiation for vestibular schwannomas: a meta-analysis of patients with more than 5 years' follow-up. Maniakas A; Saliba I Otol Neurotol; 2012 Feb; 33(2):230-8. PubMed ID: 22222572 [TBL] [Abstract][Full Text] [Related]
20. Hearing preservation after gamma knife stereotactic radiosurgery of vestibular schwannoma. Paek SH; Chung HT; Jeong SS; Park CK; Kim CY; Kim JE; Kim DG; Jung HW Cancer; 2005 Aug; 104(3):580-90. PubMed ID: 15952200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]